Patrick Badertscher: PVI With vs Without Posterior Wall Isolation in Persistent AF
Patrick Badertscher, Privat-Docent (PD) in Cardiology at University of Basel, shared a post on LinkedIn about a recent article by Laurent Roten et al., published in JAMA, adding:
“Exited to share PIFPAF-PFA.
Today, the PIFPAF-PFA randomized trial was presented as a Late-Breaking Clinical Trial at ESC Congress 2026 and simultaneously published in JAMA
We asked: In persistent AF, should posterior wall isolation be added to PVI when using pulsed-field ablation?
PVI and PWI did not significantly improve freedom from atrial tachyarrhythmia compared with PVI alone.
However, continuous rhythm monitoring showed lower arrhythmia burden and fewer longer-lasting episodes with PWI.
Our findings challenge us to look beyond the traditional greater-than-30-second recurrence endpoint when assessing AF ablation outcomes.
Proud to have been part of this investigator-initiated trial and grateful to all patients, investigators, study teams, and participating centers who made it possible.”
Title: Pulmonary Vein Isolation Using Pulsed Field Ablation With vs Without Posterior Wall Isolation in Patients With Symptomatic Persistent Atrial Fibrillation
Authors: Laurent Roten, Jens Maurhofer, Philipp Krisai, Alexander Breitenstein, Pascal Koepfli, Ardan M. Saguner, Florian Franzeck, Patrizio Pascale, Thomas Kueffer, Sven Knecht, Corinne Jufer, Valon Spahiu, Nicolas Schaerli, Claudia Herrera Siklody, Gregor Thalmann, Nikola Kozhuharov, Boldizsar Kovacs, Felix Mahfoud, Dik Heg, Tiago V. Pereira, Helge Servatius, Hildegard Tanner, Michael Kühne, Christian Sticherling, Tobias Reichlin, Peter Jüni, Patrick Badertscher
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 30, 2026, 16:52Tosin Ola: A New Era in Sickle Cell Disease Treatment and the Question of Access
-
Oct 30, 2026, 16:48Cedric Hermans: The Next Generation of FVIIIa-Mimetic Antibodies in Haemophilia A
-
Oct 30, 2026, 16:44Shehab Mohamed: Recognizing Isolated Thrombocytopenia as a Presentation of MDS
-
Oct 30, 2026, 16:40Amrita Sarkar: Advancing the Diagnosis of Anti-PF4 Syndromes
-
Oct 30, 2026, 16:35James Garrard: Driving Innovation in Stroke Care Through Global Collaboration
-
Oct 30, 2026, 16:19Cesar de Almeida Neto: Hemo 2026 Roundtable Focuses on the Challenges of Patient Blood Management
-
Oct 30, 2026, 16:01Marilena Vrana: The Case for Retaining Immunoglobulins on the EU Critical Medicines List
-
Oct 30, 2026, 15:53Ilenia Calcaterra: Patient Blood Management Across Complex Hematological Conditions
-
Oct 30, 2026, 15:40Isabella Presch: The Practicalities of Gene Therapy Adoption in Hemophilia